DrugPatentWatch Database Preview
CHANTIX Drug Profile
When do Chantix patents expire, and what generic alternatives are available?
Chantix is a drug marketed by Pf Prism Cv and is included in one NDA. There are three patents protecting this drug and one Paragraph IV challenge.
The generic ingredient in CHANTIX is varenicline tartrate. There are eleven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the varenicline tartrate profile page.
Summary for CHANTIX
| US Patents: | 3 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 8 |
| Clinical Trials: | 61 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for CHANTIX |
| DailyMed Link: | CHANTIX at DailyMed |
Generic Entry Opportunity Date for CHANTIX
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Pharmacology for CHANTIX
| Drug Class | Partial Cholinergic Nicotinic Agonist |
| Mechanism of Action | Partial Cholinergic Nicotinic Agonists |
Medical Subject Heading (MeSH) Categories for CHANTIX
US Patents and Regulatory Information for CHANTIX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pf Prism Cv | CHANTIX | varenicline tartrate | TABLET;ORAL | 021928-001 | May 10, 2006 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Pf Prism Cv | CHANTIX | varenicline tartrate | TABLET;ORAL | 021928-002 | May 10, 2006 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Pf Prism Cv | CHANTIX | varenicline tartrate | TABLET;ORAL | 021928-001 | May 10, 2006 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for CHANTIX
| Drugname | Dosage | Strength | RLD | Date |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 0.5 mg and 1 mg | ➤ Subscribe | ➤ Sign Up |
International Patents for CHANTIX
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Brazil | 9816186 | ➤ Sign Up |
| World Intellectual Property Organization (WIPO) | 9935131 | ➤ Sign Up |
| Bulgaria | 108343 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for CHANTIX
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 442 | Luxembourg | ➤ Sign Up | 91442, EXPIRES: 20210926 |
| C021/2008 | Ireland | ➤ Sign Up | SPC021/2008: 20081105, EXPIRES: 20210925 |
| 2008010,C1044189 | Lithuania | ➤ Sign Up | PRODUCT NAME: VARENICLINUM TARTRAT; REGISTRATION NO/DATE: EU/1/06/360/001 - EU/1/06/360/010, 0060926 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
